Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | PLG | P00747 | 1/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | CTSG | P08311 | 1/20 | 0.43 |
| ▸ | CMA1 | P23946 | 1/20 | 0.43 |
| ▸ | CTRC | Q99895 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (Chloromethyl)Benzene SCHEMBL1331085 | 1.00 | — | — | |
| (Chloromethyl)Benzene SCHEMBL29919724 | 1.00 | — | — | |
| SCHEMBL21317609 | 1.00 | CALM1 (0.53) | CALM1TSHRALDH1A1LOXL2IDO1 | |
| (Chloromethyl)Benzene SCHEMBL29794364 | 1.00 | — | — | |
| (Chloromethyl)Benzene SCHEMBL7413 | 1.00 | — | — | |
| (Chloromethyl)Benzene SCHEMBL1616642 | 1.00 | — | — | |
| (Chloromethyl)Benzene SCHEMBL6422666 | 1.00 | CALM1 (0.53) | CALM1TSHRALDH1A1LOXL2IDO1 | |
| (Chloromethyl)Benzene SCHEMBL7634625 | 0.97 | CALM1 (0.50) | CALM1TSHRALDH1A1LOXL2IDO1 | |
| (Chloromethyl)Benzene SCHEMBL712801 | 0.97 | CALM1 (0.50) | CALM1TSHRALDH1A1LOXL2IDO1 | |
| (Chloromethyl)Benzene SCHEMBL7537274 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | JSI SILICONE CO. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-20210188739-A1 | METHOD FOR PRODUCING ARENE COMPOUNDS AND ARENE COMPOUNDS PRODUCED BY THE SAME | JSI SILICONE CO. (KR) | 2021-06-24 | — | — | US | disclosed |
| WO-2020035432-A1 | AN AQUEOUS, STORAGE-STABLE COMPOSITION CONTAINING N-BENZYL-SUBSTITUTED N-(2-AMINOETHYL)-3-AMINOPROPYLSILOXANE HYDROCHLORIDES, PROCESSES FOR PRODUCTION THEREOF AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2020-02-20 | — | — | WO | disclosed |
| CN-103214450-B | 1-(benzo [D] [1,3] dioxole-5-base)-N-(phenyl) cyclopropane-carboxamides derivatives as ATP-binding cassette transport protein regulator | 弗特克斯药品有限公司 | 2016-10-05 | — | — | CN | disclosed |
| CN-105749850-A | Special reactor for oriented synthesis of p-chlorotoluene | 南京科技职业学院 | 2016-07-13 | — | — | CN | disclosed |
| CN-103214450-A | Modulators of atp-binding cassette transporters | VERTEX PHARMA | 2013-07-24 | — | — | CN | disclosed |
| CN-101395147-B | 1- (benzo [ D ] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane-carboxamide derivatives and related compounds as modulators of ATP-binding cassette transporters for the treatment of cystic fibrosis | VERTEX PHARMA | 2013-05-29 | — | — | CN | disclosed |
| CN-102702078-A | Method for preparing donepezil hydrochloride | YANGZIJIANG PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOG PHARMACEUTICAL CO LTD | 2012-10-03 | — | — | CN | disclosed |
| CN-101395147-A | 1- (benzo [ D ] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane-carboxamide derivatives and related compounds as modulators of ATP-binding cassette transporters for the treatment of cystic fibrosis | VERTEX PHARMA (US) | 2009-03-25 | — | — | CN | disclosed |
| WO-2008121322-A1 | A METHOD OF TREATING NEUROBLASTOMA | DUKE UNIVERSITY (US) | 2008-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210188739-A1 | METHOD FOR PRODUCING ARENE COMPOUNDS AND ARENE COMPOUNDS PRODUCED BY THE SAME | PFAS, FRK, AGPAT2 | CALM1 2648/4885TSHR 2847/4885ALDH1A1 676/4885 |
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | PFAS, FRK, AGPAT2 | CALM1 2648/4885TSHR 2847/4885ALDH1A1 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.